StemCells (STEM) Posts Q3 Loss of 5c, Tops by 2c
More News related to STEM
- StemCells, Inc. CEO Martin McGlynn Featured On BioBusiness.TV's "Stem Cell Review" Series
- StemCells (STEM) Begins Recruitment for HuCNS-SC Phase I
- StemCells, Inc. Initiates Landmark Trial Targeting "Communication Highway" of the Brain
- StemCells (STEM) Provides Update for Human Stem Cells and Batten Disease
- StemCells, Inc. Provides Update on NCL Program Meeting with FDA
More News related to Earnings
- Kopin (KOPN) Files $100M Mixed Shelf
- Benihana (BNHN) Files $30M Mixed Shelf
- Affymax (AFFY) Closes Stock Offering, Receiving Net Proceeds of $80M
- Berkshire Hills (BHLB) Files $150M Mixed Shelf
- Tenneco (TEN) Completes 12M Common Offering; Receives $187M in Net Proceeds
StemCells Inc. (NASDAQ: STEM) reports Q3 loss of $0.05, 2 cents better than the analyst estimate of ($0.07). Revenue for the quarter was $253,000, which compares to the estimate of $180,000.
Related Categories
EarningsStocks Mentioned
+0.04Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
